Theratechnologies Inc T.TH

Alternate Symbol(s): THTX

Healthcare Biotechnology

Theratechnologies Inc. is a Canada-based clinical-stage biopharmaceutical company. The Company is focused on the development and commercialization of therapies addressing unmet medical needs. It markets prescription products for people with human immunodeficiency viruses (HIV) in the United States. The Company's research pipeline focuses on specialized therapies addressing unmet medical needs in HIV, nonalcoholic steatohepatitis (NASH) and oncology. Its medicines include Trogarzo and EGRIFTA SV (tesamorelin for injection). Trogarzo (ibalizumab-uiyk) injection is a long-acting monoclonal antibody which binds to domain 2 of the CD4 T cell receptors. EGRIFTA SV (tesamorelin for injection) is approved in the United States for the reduction of excess abdominal fat in people with HIV who have lipodystrophy. Its portfolio includes Phase I clinical trial of sudocetaxel zendusortide (TH1902), a novel peptide-drug conjugate (PDC), in patients with advanced ovarian cancer.

TSX:TH - Post by User

Theratechnologies Inc > Downgraded to 3, from 8…. With everything going on?!?

<< Previous

Bullboard Posts

Next >>

Comment by palinc2000on Jul 29, 2021 11:51am

106 Views

Post# 33623414

RE:RE:RE:RE:RE:Downgraded to 3, from 8…. With everything going on?!?

I still dont understand why Paul has not yet made a CFO change,,,,,I really think he is part of the problem,,Analysts have to be spoon fed and they hate to be made looking loke fools,,,Going from 12 to 8 to 3 shows how bad communications have beeen,,,,So 12$ was way too high and I think 3 is too low but I dont expect Eddie to be the first to upgrade when and if positive developments occur

<< Previous

Bullboard Posts

Next >>

Investors eye Australian gold mining projects amid promising developments